Among the underlying mechanisms of RL’s action tested parallel in vitro was the proliferation blockage at the G1/S phase of the cell cycle, the increase in the reactive oxygen species levels in the tumor, the upregulation of Bax and Bim proteins, and the upregulation of Bcl-2 and cyclin D1 protein. The gene discussed is BCL2; the disease is neoplasm.